MedPath

ow-dose combined oral contraceptives use is associated to lower bone mass in adolescents over a one-year period

Not Applicable
Conditions
G11.427.100
Bone Mineral Density, Bone Mineral Content
G11.427
Registration Number
RBR-5h9b3c
Lead Sponsor
Faculdade de Medicina de Botucatu da Universidade Estadual Paulista Julio de Mesquita Filho
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruitment completed
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

healthy female volunteers; between 12 and 20 years old; who were post menarche and had regular menstrual cycles; attending the Adolescent Medicine Outpatient Clinic at Botucatu University Hospital from the São Paulo State University -UNESP; not using any type of hormonal contraceptive.

Exclusion Criteria

premature or low birth weight; prolonged steroid treatment; with diabetes mellitus, acute or chronic malnutrition, congenital or acquired bone diseases, gastrointestinal malabsorption, history of nephropathy, endocrinopathies; early or late puberty; chronic drug consumption; use of medication known to negatively affect bone metabolism.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the Bone Mineral Density evaluated with dual-energy X-ray absorptiometry (DXA) using a Hologic QDR 4500 Discovery A apparatus of adolescents using low dose contraceptives with results from healthy adolescents not using contraceptives.;Contraceptives users presented low bone mass acquisition in the lumbar spine bone mineral density with variation percentages between initial and final moments (+2.07%). The control group presented variations (+12.16%) over the same period.
Secondary Outcome Measures
NameTimeMethod
The use of a low COC dose with Ethinylestradiol 20µg/Desogestrel 150µg was associated to lower bone mass acquisition in adolescents during the study period.
© Copyright 2025. All Rights Reserved by MedPath